March 16, 2022 8:39 am

Pfizer Requests FDA Authorization for 2nd Booster in Seniors

Pfizer asked the FDA Tuesday to authorize a second booster dose of its COVID-19 vaccine for Americans ages 65 and over.

US & World Videos

Exit mobile version